Hong Kong, August 03, 2016 -- Moody's Investors Service says that the proposed acquisition of Gland Pharma Limited (unrated) as well as a stake in Banco Comercial Portugues, S.A. (BCP, B1/bank deposit rating, stable) by companies related to Fosun International Limited will not immediately affect Fosun's Ba3 corporate family rating or the stable outlook on the rating.

Vollständigen Artikel bei Moodys lesen